Adepthera LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersPalo Alto, CA
US patents4
SAM.gov UEIQDWUGUNKHMT5
CAGE code6M1S1
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2021–2024, 4 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Peptide analogsUS 12,110,318 · granted OCT 8, 2024
- Dosing and use of long-acting CLR/ramp agonistsUS 11,701,409 · granted JUL 18, 2023
- Peptide analogsUS 11,390,657 · granted JUL 19, 2022
- Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormonesUS 11,034,745 · granted JUN 15, 2021
Granted to Adepthera LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Adepthera LLC | Palo Alto | CA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.